Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

415 trials with published results (11%)

Research Maturity

1985 completed trials (51% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

7.7%

298 terminated out of 3879 trials

Success Rate

86.9%

+0.4% vs benchmark

Late-Stage Pipeline

6%

238 trials in Phase 3/4

Results Transparency

21%

415 of 1985 completed with results

Key Signals

415 with results87% success298 terminated

Data Visualizations

Phase Distribution

2,690Total
Not Applicable (1455)
Early P 1 (31)
P 1 (620)
P 2 (346)
P 3 (172)
P 4 (66)

Trial Status

Completed1,985
Recruiting621
Unknown476
Terminated298
Active Not Recruiting170
Not Yet Recruiting164

Trial Success Rate

86.9%

Benchmark: 86.5%

Based on 1985 completed trials

Clinical Trials (3879)

Showing 20 of 20 trials
NCT05436327Not ApplicableActive Not RecruitingPrimary

Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers

NCT05588141Phase 1Recruiting

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

NCT06329531RecruitingPrimary

Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic

NCT06801041Phase 2Recruiting

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

NCT07532057Not ApplicableCompletedPrimary

The Effect of Pulmonary Rehabilitation on Pulmonary Function Tests, Exercise Capacity, and Quality of Life in Patients With Advanced-Stage Lung Cancer Receiving Chemotherapy

NCT01057953Not ApplicableCompletedPrimary

Oligogenic Determinism of Colorectal Cancer

NCT01633021Completed

Developing the Family Map: Looking at Communal Coping

NCT05836857Active Not RecruitingPrimary

The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study

NCT03952624Recruiting

Patient-Centered Assessment of Symptoms and Outcomes

NCT04464226Phase 3Active Not RecruitingPrimary

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

NCT07532018Phase 1Recruiting

DXP-106 in Solid Tumor Patients.

NCT01481532Phase 1Not Yet RecruitingPrimary

Open Label Clinical Trial of Intravenous Crotoxin Part 3

NCT07305740Not ApplicableRecruitingPrimary

On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety

NCT06892158Not ApplicableRecruitingPrimary

Massage Impact on Sleep in Pediatric Oncology

NCT05164016CompletedPrimary

Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients

NCT05376891RecruitingPrimary

Met Non Small Cell Cancer Registry (MOMENT)

NCT07528547Not ApplicableRecruitingPrimary

Hypersight and Ethos In Pediatric Radiotherapy

NCT07342335RecruitingPrimary

Breaking Barriers to Research Access

NCT07530666Phase 1Not Yet RecruitingPrimary

Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia

NCT04452825Not ApplicableRecruitingPrimary

A New Psychotherapy Intervention for Older Cancer Patients

Scroll to load more

Research Network

Activity Timeline